MétaCan
Menu
Back to cohort
Record W4225320237 · doi:10.1016/j.waojou.2022.100627

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

2022· article· en· W4225320237 on OpenAlexafffund
Marcus Maurer, Markus Magerl, Stephen Betschel, Werner Aberer, Ignacio J. Ansotegui, Emel Aygören‐Pürsün, Aleena Banerji, Noémi‐Anna Bara, Isabelle Boccon‐Gibod, Konrad Bork, Laurence Bouillet, Henrik Balle Boysen, Nicholas Brodszki, Paula J. Busse, Anette Bygum, Teresa Caballero, Mauro Cancian, Anthony J. Castaldo, Danny M. Cohn, Dorottya Csuka, Henriette Farkas, Mark Gompels, Richard Gower, Anete Sevciovic Grumach, Guillermo Guidos Fogelbach, Michihiro Hide, Hye‐Ryun Kang, Allen P. Kaplan, Constance H. Katelaris, Sorena Kiani‐Alikhan, Wei‐Te Lei, Richard F. Lockey, Hilary Longhurst, William R. Lumry, Andrew J. MacGinnitie, Alejandro Malbrán, Inmaculada Martinez Saguer, Juan José Matta Campos, Alexander Nast, Dinh Van Nguyen, Sandra Nieto-Martínez, Ruby Pawankar, Jonny Peter, Grzegorz Porębski, Nieves Prior, Avner Reshef, Marc A. Riedl, Bruce Ritchie, Farrukh Sheikh, William Smith, Peter J. Spaeth, Marcin Stobiecki, Elias Toubi, Lilian Varga, Karsten Weller, Andrea Zanichelli, Yuxiang Zhi, Bruce L. Zuraw, Timothy Craig

Bibliographic record

VenueWorld Allergy Organization Journal · 2022
Typearticle
Languageen
FieldMedicine
TopicCoagulation, Bradykinin, Polyphosphates, and Angioedema
Canadian institutionsUniversity of AlbertaUniversity of Toronto
FundersGenentechGrifolsUniversity of AlbertaBioCrystCSL BehringIpsenTeva Pharmaceutical IndustriesRegeneron PharmaceuticalsSanofiPfizer
KeywordsHereditary angioedemaGuidelineMedicineDelphi methodC1-inhibitorDelphiIntensive care medicineDiseaseAngioedemaFamily medicinePathologyDermatology

Abstract

fetched live from OpenAlex

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.020
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.017
Threshold uncertainty score0.035

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.020
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0050.003
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0050.006
Insufficient payload (model declined to judge)0.0100.008

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.251
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations151
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueWorld Allergy Organization JournalSame topicCoagulation, Bradykinin, Polyphosphates, and AngioedemaFrench-language works237,207